Castle Biosciences, Inc.CSTLNASDAQ
Loading
Gross Margin Over TimeContracting
Percentile Rank13
3Y CAGR-3.6%
5Y CAGR-4.1%
Year-over-Year Change
Gross profit as a percentage of revenue
3Y CAGR
-3.6%/yr
vs -0.0%/yr prior
5Y CAGR
-4.1%/yr
Consistent
Acceleration
-3.6pp
Decelerating
Percentile
P13
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | 68.66% | -16.1% |
| 2024 | 81.87% | +2.9% |
| 2023 | 79.53% | +3.8% |
| 2022 | 76.64% | -7.9% |
| 2021 | 83.18% | -1.6% |
| 2020 | 84.54% | -1.6% |
| 2019 | 85.91% | +11.9% |
| 2018 | 76.75% | +19.5% |
| 2017 | 64.21% | - |